tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Cash flow

267 Followers

Enliven Therapeutics Cash Flow

ELVN's free cash flow for Q1 2024 was $-23.38M. For the 2024 fiscal year, ELVN's free cash flow was decreased by $-61.42M and operating cash flow was $-23.36M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Jan 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -51.38M$ -61.27M-$ -35.57M$ -46.77M$ -37.40M
Investing Cash Flow
$ -204.98M$ -148.41M-$ 76.52M$ -1.63M$ -16.72M
Financing Cash Flow
$ 87.14M$ 234.29M-$ -1.23M$ 49.10M$ 96.88M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 361.84M$ 100.19M-$ 88.19M$ 48.48M$ 47.79M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ -1.42M$ 161.37M---$ 97.58M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -51.53M$ -61.42M-$ -931.00K$ -46.78M$ -37.42M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Enliven Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis